Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 9Phase 1/2 4Phase 4 3Phase 3 3Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 347Recruiting 234Terminated 181Unknown 128Active not recruiting 104Withdrawn 45Not yet recruiting 31Suspended 4Enrolling by invitation 2

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 14Other hematologic neoplasm 7Lymphoid 6Dermatologic 5Tumor-Agnostic 4Thoracic 4CNS 4Other solid neoplasm 3Myeloid 3Genitourinary 3Breast 3Sarcoma 2Plasma cell 2Gynecologic 2NET 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Lung Neoplasms 2Neoplasms, Squamous Cell 1Neoplasm, Residual 1Mesothelioma, Malignant 1Mesothelioma 1Esophageal Neoplasms 1Carcinoma 1

Interventions

pembrolizumab 1Monatide (IMS 3015) 1Injections 1Eflornithine 1Biological Products 1Biological Assay 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Suspended × Thoracic × Clear all
NCT05642195 2026-05-27

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Suspended
30 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT04908111 2026-04-06

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

Cancer Research UK

Phase 1/2 Suspended
15 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT06219174 2026-03-06

Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Suspended
45 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01627795 2018-04-18

Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment

Oshadi Drug Administration

Phase 1/2 Suspended
17 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡